AzTrials
AzTrials

Critically IllNCT06705374

Central Venous Pressure and Right Atrial Pressure Measurements in Supine, Semi-recumbent and Trendelenburg Position

An observational study of Critically Ill, run by Vastra Gotaland Region at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intensive care is directed towards patients with severe illness or risk of serious outcomes following, for example, surgery. Central venous pressure (CVP) is an important part of the hemodynamic assessment of patients in surgery and the intensive care unit (ICU). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critically Ill
How many people
16 participants
Where
1 siteSweden
Study dates
15 Nov 2023to 30 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Critically ill patients, in mechanical ventilation, sedated to RASS -4 or -5 in mechanical ventilation with a 4 or 5 line CVC.

Who may be able to join

  • Critically ill patients in mechanical ventilation with an arterial line and a four or five lumen CVC.

Who cannot join

  • under 18 years of age
  • in a dynamic phase of their illness i.e. ongoing treatment of severe circulatory or respiratory failure
  • positive end-expiratory pressure (PEEP) >14 cmH20 or intolerance to change of body position.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Sahlgrenska University Hospital

    Gothenburg, Västra Götaland County, 41345

Other trials in Sweden

About this study

Intensive care is directed towards patients with severe illness or risk of serious outcomes following, for example, surgery. Central venous pressure (CVP) is an important part of the hemodynamic assessment of patients in surgery and the intensive care unit (ICU). CVP is normally measured via a central venous catheter (CVC) inserted through the subclavian or internal jugular vein, with the tip placed at the junction to the right atrium. A pressure tubing is connected to one of the branches of the CVC and then connected to a pressure sensor that sends a digital signal to the monitoring screen where CVP can be read in mmHg. To accurately read CVP, the pressure sensor must be positioned at the level of the right atrium. Different external reference points are used nationally and internationally to locate the correct height for the pressure sensor. This study aims to investigate the most commonly used external reference points for CVP measurement in various body positions compared to CVP measured via a solid state pressure catheter in the right atrium (RAP).

Read the detailed description

A Millar Mikro-Cath solid state pressure catheter is inserted through one of the medial lines of the CVC and guided in position by the pressure curve and verified in position by ultrasound.

CVP is compared to RAP in supine, semi-recumbent, Trendelenburg and lateral position.

CVP, RAP and arterial pressure is recorded in each session with Biopac Acqnowledge.

In each body position PEEP is raised 5 cmH20 and then lowered 5 cmH20.

Ventilator settings, capillary refill time, perfusion index are collected in each setting and before and after PEEP adjustments.

Conditions
Critically Ill
Medical subject headings
Critical Illness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in mmHg between Right atrial pressure (RAP) and Central venous pressure (CVP) in supine position

    Difference in mmHg between RAP (Millar Micro-Cath) and CVP.

    Measured: 3 minutes after body position change

  2. Difference in mmHg between RAP and CVP in semi-recumbent position

    Difference in mmHg between RAP (Millar Micro-Cath) and CVP.

    Measured: 3 minutes after body position change

  3. Difference in mmHg between RAP and CVP in Trendelenburg position

    Difference in mmHg between RAP (Millar Micro-Cath) and CVP.

    Measured: 3 minutes after body position change

  4. Difference in mmHg between RAP and CVP in right lateral position

    Difference in mmHg between RAP (Millar Micro-Cath) and CVP.

    Measured: 3 minutes after body position change

  5. Difference in mmHg between RAP and CVP in left lateral position

    Difference in mmHg between RAP (Millar Micro-Cath) and CVP.

    Measured: 3 minutes after body position change

Secondary outcomes (10)
  1. Change in hemodynamic parameters after body position change

    Change in CVP (mmHg)

    Measured: 3 minutes after body position change

  2. Change in hemodynamic parameters after PEEP change

    Change in RAP (mmHg)

    Measured: 1 minutes after PEEP change

  3. Change in hemodynamic parameters after body position change

    Change in arterial pressure (mmHg)

    Measured: 3 minutes after body position change

  4. Change in hemodynamic parameters after body position change

    Change in perfusion index (%)

    Measured: 3 minutes after body position change

  5. Change in hemodynamic parameters after body position change

    Change in capillary refill time change (sek)

    Measured: 3 minutes after body position change

  6. Change in hemodynamic parameters after body position change

    Change in RAP (mmHg)

    Measured: 3 minutes after body position change

  7. Change in hemodynamic parameters after PEEP change

    Change in CVP (mmHg)

    Measured: 1 minutes after PEEP change

  8. Change in hemodynamic parameters after PEEP change

    Change in arterial pressure (mmHg)

    Measured: 1 minutes after PEEP change

  9. Change in hemodynamic parameters after PEEP change

    In capillary refill time change (sek)

    Measured: 1 minutes after PEEP change

  10. Change in hemodynamic parameters after PEEP change

    Change in perfusion index (%)

    Measured: 1 minutes after PEEP change

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start15 Nov 2023
  3. Primary completion15 Dec 2024
  4. Study completion30 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06705374
Sponsor's protocol ID
CVP/RAP
Status last verified
May 2025
First submitted
30 Apr 2024
Last updated
20 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All excel data that underlie results in publication

Publications

  • Sjodin C, Oras J, Johansson L, Persson P, Olausson S, Holmqvist J, Ille A, Vidovic N, Svensson CJ. Central Venous Pressure Referencing in the Lateral Position: Comparison With Direct Right Atrial Pressure in Mechanically Ventilated ICU Patients. Acta Anaesthesiol Scand. 2026 Jul;70(6):e70280. doi: 10.1111/aas.70280.

    PubMed 42285730

Questions about this trial

What is this clinical trial studying?

An observational study of Critically Ill, run by Vastra Gotaland Region at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in mmHg between Right atrial pressure (RAP) and Central venous pressure (CVP) in supine position (time frame: 3 minutes after body position change). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06705374, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in